Synapse - Maureen Zakowski

Search Within

Maureen F Zakowski

Results (289)

Performance of cytologic specimens in EGFR and KRAS molecular testing with a focus on minimal cellularity requirements

Meeting Abstract

Brandt, S. M.; Tafe, L. J.; Arcila, M. E.; Moreira, A. L.; Zakowski, M. F.; Ladanyi, M.; Rekhtman, N.
Laboratory Investigation (2011)

Fulltext@MSK | Save

Comprehensive analysis for clinically relevant oncogenic driver mutations in 1131 consecutive lung adenocarcinomas

Meeting Abstract

Arcila, M. E.; Lau, C.; Jhanwar, S.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
Laboratory Investigation (2011)

Fulltext@MSK | Save

Policies and reporting guidelines for small biopsy specimens of mediastinal masses

Journal Article

Marchevsky, A.; Marx, A.; Ströbel, P.; Suster, S.; Venuta, F.; Marino, M.; Yousem, S.; Zakowski, M.
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Journal Article

Bott, M.; Brevet, M.; Taylor, B. S.; Shimizu, S.; Ito, T.; Wang, L.; Creaney, J.; Lake, R. A.; Zakowski, M. F.; Reva, B.; more...
Nature Genetics (2011)

Fulltext@MSK | Save

Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene

Journal Article

Rizvi, N. A.; Rusch, V.; Pao, W.; Chaft, J. E.; Ladanyi, M.; Miller, V. A.; Krug, L. M.; Azzoli, C. G.; Bains, M.; Downey, R.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: High accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing

Journal Article

Rekhtman, N.; Brandt, S. M.; Sigel, C. S.; Friedlander, M. A.; Riely, G. J.; Travis, W. D.; Zakowski, M. F.; Moreira, A. L.
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations

Journal Article

Janjigian, Y. Y.; Park, B. J.; Zakowski, M. F.; Ladanyi, M.; Pao, W.; D'Angelo, S. P.; Kris, M. G.; Shen, R.; Zheng, J.; Azzoli, C. G.
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save

Incidence of EGFR Exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas

Journal Article

D'Angelo, S. P.; Pietanza, M. C.; Johnson, M. L.; Riely, G. J.; Miller, V. A.; Sima, C. S.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay

Journal Article

Arcila, M. E.; Oxnard, G. R.; Nafa, K.; Riely, G. J.; Solomon, S. B.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Miller, V. A.; Ladanyi, M.
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Frequency of EGFR and KRAS mutations in lung adenocarcinomas in african americans

Journal Article

Reinersman, J. M.; Johnson, M. L.; Riely, G. J.; Chitale, D. A.; Nicastri, A. D.; Soff, G. A.; Schwartz, A. G.; Sima, C. S.; Ayalew, G.; Lau, C.; more...
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save